Results 1 to 10 of about 74,680 (298)

Analysis of risk factors for polypharmacy and excessive polypharmacy [PDF]

Frontiers in Medicine
BackgroundPolypharmacy is a growing global concern, particularly among older adults with multimorbidity. Fragmented care and consultations across multiple medical institutions may further increase medication burden.
Shigeto Mashiko, Yuiko Suzuki, Yurika Hirota, Hatsuho Ejima, Ryo Nonaka, Saki Nakayama, Emiko Kurosawa, Katsutoshi Furukawa   +7 more
doaj   +2 more sources

Prevalence and factors associated with polypharmacy: a systematic review and Meta-analysis

BMC Geriatrics, 2022
Introduction Polypharmacy is commonly associated with adverse health outcomes. There are currently no meta-analyses of the prevalence of polypharmacy or factors associated with polypharmacy.
Mahin Delara, Lauren Murray, Behnaz Jafari, Anees Bahji, Zahra Goodarzi, Julia Kirkham, Zia Chowdhury, Dallas P. Seitz   +7 more
doaj   +1 more source

Polypharmacy trajectories among older women with and without dementia: A longitudinal cohort study

Exploratory Research in Clinical and Social Pharmacy, 2021
Background: Although multiple medications are often utilized to achieve optimal treatment outcomes, polypharmacy (use of five or more medications) among older population is associated with several detrimental effects.
Kailash Thapaliya, Melissa L. Harris, Julie E. Byles   +2 more
doaj   +1 more source

Defining polypharmacy: in search of a more comprehensive determination method applied in a tertiary psychiatric hospital

Therapeutic Advances in Psychopharmacology, 2021
Aims: This cross-sectional pharmacoepidemiologic study examined the prevalence of polypharmacy and psychotropic polypharmacy among inpatients in a tertiary psychiatric hospital in Belgium.
Jeroen Govaerts, Julie Boeyckens, Astrid Lammens, Annelies Gilis, Filip Bouckaert, Marc De Hert, Jan De Lepeleire, Brendon Stubbs, Franciska Desplenter   +8 more
doaj   +1 more source

Polypharmacy prevalence in older adults seen in United States physician offices from 2009 to 2016.

PLoS ONE, 2021
Background/objectivesWith an aging population suffering from increased prevalence of chronic conditions in the United States (U.S.), a large portion of these patients are on multiple medications.
Eric H Young, Samantha Pan, Alex G Yap, Kelly R Reveles, Kajal Bhakta   +4 more
doaj   +1 more source

Aging and the Prevalence of Polypharmacy and Hyper-Polypharmacy Among Older Adults in South Korea: A National Retrospective Study During 2010–2019

Frontiers in Pharmacology, 2022
Background: Polypharmacy has become a global health problem and is associated with adverse health outcomes in the elderly. This study evaluated the prevalence of polypharmacy and hyper-polypharmacy in elderly patients in South Korea during 2010–2019 ...
Ho Jin Cho, Jungmi Chae, Sang-Heon Yoon, Dong-Sook Kim   +3 more
doaj   +1 more source

An Increasing Trend in the Prevalence of Polypharmacy in Sweden: A Nationwide Register-Based Study

Frontiers in Pharmacology, 2020
AimPolypharmacy is becoming a global health problem. The aims of this study were to evaluate the temporal trends in the prevalence of polypharmacy in Sweden and to explore polypharmacy disparities by age, gender, education, and immigration status ...
Naiqi Zhang, Jan Sundquist, Jan Sundquist, Jan Sundquist, Kristina Sundquist, Kristina Sundquist, Kristina Sundquist, Jianguang Ji   +7 more
doaj   +1 more source

The evolution of polypharmacy: appropriate and problematic polypharmacy, choosing the right strategy and tactics

Медицинский совет, 2021
The evolution of polypharmacy, which for many years consisted of quantifying concurrently prescribed drugs, has led to an qualitative description: “appropriate polypharmacy”, which may be beneficial for some patients, and “problematic polypharmacy ...
M. V. Leonova
doaj   +1 more source

Factors related to polypharmacy and hyper‐polypharmacy for the elderly: A nationwide cohort study using National Health Insurance data in South Korea

Clinical and Translational Science, 2023
Polypharmacy may cause adverse health outcomes in the elderly. This study examined the prevalence of continuous polypharmacy and hyper‐polypharmacy, factors associated with polypharmacy, and the most frequently prescribed medications among older adults ...
Ho Jin Cho, Jungmi Chae, Sang‐Heon Yoon, Dong‐Sook Kim   +3 more
doaj   +1 more source

Factors associated with polypharmacy and excessive polypharmacy in older people with intellectual disability differ from the general population: a cross-sectional observational nationwide study

BMJ Open, 2016
Objectives (1) To evaluate the prevalence of polypharmacy (5–9 medicines) and excessive polypharmacy (10+ medicines) and (2) to determine associated demographic and clinical characteristics in an ageing population with intellectual disabilities (IDs ...
Mary McCarron, Philip McCallion, Máire O'Dwyer, Jure Peklar, Martin C Henman   +4 more
doaj   +1 more source